Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 2476 AL 2490

The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype

Cooper-Knock J, Shaw PJ, Kirby J.

Acta Neuropathol. 2014 Mar;127(3):333-45. doi: 10.1007/s00401-014-1251-9. Epub 2014 Feb 4.

Feasibility of Huntington disease trials in the disease prodrome

McCusker EA, Myers RH.

Neurology. 2014 Mar 11;82(10):824-5. doi: 10.1212/WNL.0000000000000197. Epub 2014 Feb 7.

PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease

Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM.

Neurology. 2014 Mar 11;82(10):850-7. doi: 10.1212/WNL.0000000000000187. Epub 2014 Feb 7.

Preimplantation diagnosis for single gene disorders

Berger VK, Baker VL.

Semin Reprod Med. 2014 Mar;32(2):107-13. doi: 10.1055/s-0033-1363552. Epub 2014 Feb 10.

[Diabetic chorea]

Takamatsu K.

Brain Nerve. 2014 Feb;66(2):121-8.

Study of cholesterol metabolism in Huntington's disease

Leoni V, Caccia C.

Biochem Biophys Res Commun. 2014 Apr 11;446(3):697-701. doi: 10.1016/j.bbrc.2014.01.188. Epub 2014 Feb 10.

Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders

Moll L, El-Ami T, Cohen E.

Swiss Med Wkly. 2014 Feb 13;144:w13917. doi: 10.4414/smw.2014.13917.

Autopsy case of concurrent Huntington's disease and neurofibromatosis type 1

Kawakami I, Katsuse O, Aoki N, Togo T, Suzuki K, Isojima D, Kondo D, Iseki E, Kosaka K, Akiyama H, Hirayasu Y.

Psychogeriatrics. 2014 Mar;14(1):81-6. doi: 10.1111/psyg.12040. Epub 2014 Feb 16.

Novel single base-pair deletion in exon 1 of XK gene leading to McLeod syndrome with chorea, muscle wasting, peripheral neuropathy, acanthocytosis and haemolysis

Wiethoff S, Xiromerisiou G, Bettencourt C, Kioumi A, Tsiptsios I, Tychalas A, Evaggelia M, George K, Makris V, Hardy J, Houlden H.

J Neurol Sci. 2014 Apr 15;339(1-2):220-2. doi: 10.1016/j.jns.2014.01.034. Epub 2014 Feb 1.

A novel heterozygous SETX mutation in a patient presenting with chorea and motor neuron disease

Saracchi E, Castelli M, Bassi MT, Brighina E, Cereda D, Marzorati L, Patassini M, Appollonio I, Ferrarese C, Brighina L.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):138-40. doi: 10.3109/21678421.2013.865751. Epub 2014 Feb 7.

Peptide therapeutics in neurodegenerative disorders

Tiwari SK, Chaturvedi RK.

Curr Med Chem. 2014;21(23):2610-31. doi: 10.2174/0929867321666140217125857.

Peptide-based therapeutic approaches for treatment of the polyglutamine diseases

Takeuchi T, Popiel HA, Futaki S, Wada K, Nagai Y.

Curr Med Chem. 2014;21(23):2575-82. doi: 10.2174/0929867321666140217124038.

A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington's disease

Collins LM, Lazic SE, Barker RA.

BMC Neurol. 2014 Feb 24;14:35. doi: 10.1186/1471-2377-14-35.

[Delayed diagnosis of juvenile Huntington's diseases: case report]

Meza Escobar LE, Orozco JL, Takeuchi Y, Ariza Y, Pachajoa H.

Arch Argent Pediatr. 2014 Feb;112(1):e23-6. doi: 10.5546/aap.2014.e23.

Can trehalose prevent neurodegeneration? Insights from experimental studies

Emanuele E.

Curr Drug Targets. 2014 May;15(5):551-7. doi: 10.2174/1389450115666140225104705.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias